Navigation Links
Video: Patient at Mother Frances Receives Heart Bypass Without Opening Chest
Date:11/16/2007

n of the advanced technology of the da Vinci system

"The approach of this procedure is similar to the way in which gall bladder surgery has been done for the last several years. It is a great advancement in cardiac care," said Dr. Turner. "I have performed 130 robotic-assisted bypasses at Mother Frances, but this new technique eliminates the need to open a 2-3 inch area between the ribs to allow an area to hand-sew the bypass from outside the body. That incision is no longer needed since the harvesting of a section of the mammary vessel from the inside of the chest wall as well as the bypass are now all done internally with the assistance of the robotic system."

"The two most invasive aspects of heart surgery are the heart lung machine and sternotomy (opening the chest cavity through the sternum)," said Dr. Turner. "With robotic surgery, we have eliminated both. Now, we have also eliminated the need for any significant incision. This is a great step forward in patient care in reducing pain and shortening recovery time. The patients are able to resume normal activity in 10 to 14 days, instead of six to eight weeks."

The da Vinci System cannot make decisions or movements on its own, explains Dr. Turner. "The surgeon makes all movements. But da Vinci makes the surgeon's movements more precise, giving more range of motion and providing enhanced 3-D visualization of the operating field. It also improves dexterity."

The da Vinci robotic surgical system has applications for many types of surgery including cardiac, urologic and general surgery procedures.

For more information on cardiac services available through the Trinity Mother Frances Heart Institute, visit http://www.tmfhs.org.


'/>"/>
SOURCE Trinity Mother Frances Heart Institute
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Virtual maps for the blind 56801 1Virtual maps for the blind 56801 2Virtual maps for the blind 56801 3Changing the course of nature 3A Are fisheries directing the evolution of fish populations 3F 9874 1Changing the course of nature 3A Are fisheries directing the evolution of fish populations 3F 9874 2Stevens to host 2009 N J Inventors Hall of Fame Dinner 9871 1Stevens to host 2009 N J Inventors Hall of Fame Dinner 9871 2